当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:152.48亿  总市值:152.48亿
流通股本:2.12亿   总股本:2.12亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.63亿元,每股收益0.32元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益324795.43万元,未分配利润106683.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产648953.87万元,负债324158.43万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入728,650,826.782,876,896,205.582,059,065,717.061,310,942,751.62
营业总成本617,062,250.992,442,468,503.311,692,413,729.41,083,752,794.05
其他经营收益
营业利润74,188,573.15296,753,268.18289,384,618.05184,723,905.82
利润总额74,142,301.06275,775,558.67287,425,117.63181,622,375.23
净利润63,006,428.85231,645,431.33231,678,855.86148,696,287.31
每股收益
其他综合收益-3,706,137.65-996,967.42-1,723,831.95-2,272,927.51
综合收益总额59,300,291.2230,648,463.91229,955,023.91146,423,359.8
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,008,893,053.73,787,891,366.553,715,026,308.813,509,468,693.46
非流动资产:
非流动资产合计2,480,645,614.242,506,382,734.42,355,409,813.772,333,077,224.83
资产总计6,489,538,667.946,294,274,100.956,070,436,122.585,842,545,918.29
流动负债:
流动负债合计1,857,269,414.821,777,506,406.921,610,886,614.771,446,644,840.33
非流动负债:
非流动负债合计1,384,314,932.361,331,029,379.671,325,955,561.831,349,479,419.53
负债合计3,241,584,347.183,108,535,786.592,936,842,176.62,796,124,259.86
所有者权益(或股东权益):
归属于母公司股东权益合计3,209,240,514.993,136,045,549.313,112,196,065.043,023,109,057.76
股东权益合计3,247,954,320.763,185,738,314.363,133,593,945.983,046,421,658.43
负债和股东权益合计6,489,538,667.946,294,274,100.956,070,436,122.585,842,545,918.29
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计802,366,515.983,054,040,753.922,096,179,872.291,342,097,615.26
经营活动现金流出小计765,795,218.422,736,291,724.32,001,600,478.351,352,528,504.77
经营活动产生的现金流量净额36,571,297.56317,749,029.6294,579,393.94-10,430,889.51
投资活动产生的现金流量:
投资活动现金流入小计1,546,637,248.884,537,927,477.473,302,942,359.662,006,738,023.23
投资活动现金流出小计1,293,794,205.484,739,970,309.923,079,541,970.951,736,278,461.61
投资活动产生的现金流量净额252,843,043.4-202,042,832.45223,400,388.71270,459,561.62
筹资活动产生的现金流量:
筹资活动现金流入小计360,643,571.48955,063,826.12701,021,475.18493,284,158.35
筹资活动现金流出小计255,066,752.42778,061,753.87497,285,337.95306,405,488.22
筹资活动产生的现金流量净额105,576,819.06177,002,072.25203,736,137.23186,878,670.13
汇率变动对现金及现金等价物的影响-17,323,622.87-1,083,949.138,282,087.8514,329,706.16
现金及现金等价物净增加额377,667,537.15291,624,320.29529,998,007.73461,237,048.4
期末现金及现金等价物余额1,542,387,530.171,164,719,993.021,403,093,680.461,334,332,721.13
补充资料:
现金及现金等价物的净增加额-291,624,320.29-461,237,048.4
最新报告期:2026-04-23
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
西部证券李梦园1.431.802.282026-04-23
TOP↑